Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pregnancy heart check: could new guidelines protect moms and babies?

NCT ID NCT05776082

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 04, 2026 · Updated 3 times

Summary

This study looks at how a pregnant woman's heart health, measured by the American Heart Association's 'Life's Essential 8' checklist, relates to outcomes for her and her baby. Researchers will follow 5,000 pregnant women in China, collecting surveys and medical data. The goal is to create heart health standards tailored to pregnancy, potentially reducing complications like high blood pressure and preterm birth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better heart health guidelines for pregnant women, helping reduce risks like high blood pressure and preterm birth.
What could go wrong
This is an observational study, not a treatment trial. It may not prove cause and effect, and results might not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This project intends to recruit pregnant women who go to the research center for routine prenatal examination and give birth.

Ages

20 to 49 years

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Maternal age: 20-49 years; * Natural conception; * Single pregnancy; * Plan to have routine prenatal examinations and give birth in the research center; Exclusion Criteria: * Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy; * Assisted reproduction; * Multiple pregnancy; * Fetus has a known deformity or genetic defects; * Incomplete clinical data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant women are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rwanda Society of Obstetricians and Gynecologists

    ACTIVE_NOT_RECRUITING

    Kigali, Rwanda

  • Taizhou First People's Hospital

    RECRUITING

    Taizhou, Zhejiang, 310000, China

  • Women's Hospital School Of Medicine Zhejiang University

    RECRUITING

    Hangzhou, Zhejiang, 310006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.